<< Semaglutide Injection / Safety and Precautions
Semaglutide Injection
Compounded semaglutide is a prescription medication used for chronic weight management in adults with obesity or overweight with at least one weight-related condition. It is not FDA-approved, but can be prescribed under federal law by a licensed provider based on your medical evaluation.
Who Should Not Use It:
Anyone with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2)
People with a known allergy to semaglutide
Patients with type 1 diabetes or a history of pancreatitis
How It Works:
Semaglutide is a GLP-1 receptor agonist that helps control appetite, improve blood sugar, and support weight loss. It is administered once weekly via subcutaneous injection in the stomach, thigh, or upper arm.
Important Warnings:
Possible risk of thyroid tumors, pancreatitis, gallbladder issues, kidney injury, low blood sugar, or increased heart rate
Report any lumps in the neck, severe abdominal pain, vision changes, or allergic reactions to your provider immediately
Avoid use during pregnancy or breastfeeding
Side Effects:
Common: nausea, diarrhea, vomiting, constipation, headache, fatigue, abdominal discomfort
Serious: thyroid tumors, pancreatitis, gallbladder disease, severe hypoglycemia, kidney injury, serious allergic reactions, or mental health changes
Precautions:
Tell your provider about all medications, supplements, and medical conditions before starting semaglutide. Do not share needles or adjust your dose without guidance.
Reporting Side Effects:
You can report side effects to FDA MedWatch at 1-800-FDA-1088 or online at www.fda.gov/medwatc